慢性前立腺炎/慢性骨盤痛症候群 (CP/CPPS) の患者における標準的な薬物療法と組み合わせた心理学的介入の効果:ランダム化制御試験
Xiu Lin1,2, Xian-Bin Pan3, Bao-Zhu Guo1
1Department of Public Health, International College, Krirk University, Bangkok, Thailand.
Medicine
|September 3, 2025
まとめ
慢性前立腺炎/慢性骨盤疼痛症候群 (CP/CPPS) の患者,特に長期間発症した患者では,標準治療に心理介入 (PI) を加えた結果が著しく改善されました. より良い結果を得るために早期のPIが推奨されます.
科学分野:
- 泌尿器科
- 精神科
- 臨床医学
背景:
- 慢性的な前立腺炎/慢性的な骨盤痛症候群 (CP/CPPS) は,しばしば不安やうつ病と併発する.
- この研究では,CP/CPPS患者のアウトカムに対する心理的介入 (PI) の影響を調査した.
研究 の 目的:
- 標準的な薬剤療法に心理的介入 (PI) を加えることで,CP/CPPSの患者のアウトカムが改善されるかどうかを評価する.
- 前立腺炎の症状と共に心理的な症状の管理におけるPIの有効性を評価する.
主な方法:
- 大人のCP/CPPS患者168人が,対照群とPI群に分けられた.
- 両群とも30日間の薬剤療法 (レボフロクサシンとタムスロシン) を受けた.
- 心理的な症状は,治療前と治療後の評価を受けた.
主要な成果:
- PIグループは,対照群と比較して,不安,うつ,前立腺炎の症状の回復が著しく改善されました.
- 病気の長さは不安,うつ,前立腺炎の症状スケールで高いスコアと相関しています.
- PIは早期に陽性な効果を示したが,疾患の進行とともに有効性が低下した.
結論:
- 抗生物質とPIを併用することは,CP/CPPSの患者,特に病歴が長く,症状が重篤な患者には有効です.
- CP/CPPSの管理における最適な治療結果のために,心理学的介入の早期実施が推奨されます.
さらに関連する動画
関連する概念動画
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Psychosis and Antipsychotic Drugs: Overview
453
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
453
Treatment Strategies for Psychological Disorders
267
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
267
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


